A Novel Strategy to Rebalance Immunity in ITP – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
In immune thrombocytopenia, tuning the enzymatic activity of CD38 restored regulatory T cell function through the deacetylase Sirt-1.
Working in patient cells and models, the authors show this approach rebalances immunity rather than broadly suppressing it, pointing to CD38 as a fresh therapeutic target that could explain durable responses in patients with ITP.”
Title: Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
Authors: Mingfang Zhu, Haoyi Wang, Yitong Xu, Yubin Li, Wanru Wang, Lingjun Wang, Ruixue Wang, Ping Zhang, Ruting Wang, Junying Cao, Lin Wang, Yan Shi, Ming Hou, Yu Hou
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 09:51Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
-
Sep 11, 2026, 09:35Yasir Khan: Travel Related Blood Clots – What Are the Chances?
-
Sep 11, 2026, 08:02Mud Alvi: Restarting Antithrombotic Therapy After Hemorrhagic Transformation of Ischemic Stroke
-
Sep 11, 2026, 08:01Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
-
Sep 11, 2026, 08:01Mariusz Kowalewski: Risk Stratification of Surgical Ablation During Minimally Invasive Mitral Valve Surgery for AFib
-
Sep 11, 2026, 08:00Noor Gajraj: MTHFR Helps Turn Folate, Vitamin B9, Into The Form The Body Uses
-
Sep 11, 2026, 07:59Lisa Lacy: Living With Hereditary Antithrombin Deficiency and the Constant Threat of Clotting
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD